Orbimed Advisors - DECIBEL THERAPEUTICS INC ownership

DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 44 filers reported holding DECIBEL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of DECIBEL THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$19,038,989
+27.5%
4,945,1920.0%0.34%
+17.7%
Q1 2023$14,934,480
+47.3%
4,945,1920.0%0.29%
+51.0%
Q4 2022$10,137,644
-40.8%
4,945,1920.0%0.19%
-39.0%
Q3 2022$17,110,000
-17.8%
4,945,1920.0%0.32%
-15.6%
Q2 2022$20,819,000
+38.5%
4,945,1920.0%0.38%
+54.5%
Q1 2022$15,033,000
-34.6%
4,945,1920.0%0.24%
-17.6%
Q4 2021$22,995,000
-39.7%
4,945,1920.0%0.30%
-29.4%
Q3 2021$38,127,000
-10.4%
4,945,1920.0%0.42%
-2.6%
Q2 2021$42,529,000
-24.3%
4,945,1920.0%0.43%
-18.1%
Q1 2021$56,177,0004,945,1920.52%
Other shareholders
DECIBEL THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ATLAS CAPITAL ADVISORS LLC 40,000$36,4000.01%
View complete list of DECIBEL THERAPEUTICS INC shareholders